You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 14, 2025

Patent: 10,072,065


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,072,065
Title:Peptide-mediated delivery of immunoglobulins across the blood-brain barrier
Abstract: Provided herein are materials and methods for delivering immunoglobulins (e.g. therapeutic immunoglobulins) across the blood-brain barrier.
Inventor(s): Sarkar; Gobinda (Rochester, MN), Jenkins; Robert B. (Rochester, MN), Curran; Geoffry L. (Rochester, MN)
Assignee: Mayo Foundation for Medical Education and Research (Rochester, MN)
Application Number:15/246,232
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Comprehensive Analysis of the Claims and Patent Landscape for United States Patent 10,072,065

Introduction

Understanding the intricacies of a patent, particularly one like United States Patent 10,072,065, involves a deep dive into its claims, the patent landscape, and the legal frameworks that govern its validity and enforceability. This analysis will cover key aspects such as subject matter eligibility, obviousness, inventorship, and the role of administrative bodies like the Patent Trial and Appeal Board (PTAB).

Patent Overview

United States Patent 10,072,065, though not specifically detailed in the provided sources, can be analyzed through the lens of general patent law principles.

Subject Matter Eligibility

Subject matter eligibility is a critical aspect of patent law, governed by 35 U.S.C. § 101. The Alice/Mayo test, a two-step framework, is used to determine whether a patent claim is directed to eligible subject matter.

Step 2A: Prong One and Prong Two

  • Prong One focuses on whether the claim elements recite one of the enumerated groupings of abstract ideas, such as mathematical concepts, methods of organizing human activity, or mental processes[2].
  • Prong Two requires demonstrating that the claims are directed to a specific, concrete technological advancement or solution to a technical problem. For AI inventions, this often involves showing improvements to the functioning of a computer or another technical field[2].

Claims Analysis

When analyzing the claims of a patent like 10,072,065, it is crucial to understand how each claim element contributes to the overall eligibility and patentability of the invention.

Claim Scope and Variations

During the prosecution process, claims may be amended or narrowed to overcome objections from the examiner or prior art. This can result in variations within a patent family, making comprehensive searches and comparisons necessary[3].

Obviousness and Double Patenting

Obviousness-type double patenting (ODP) is another significant consideration. ODP prevents an inventor from securing a second, later-expiring patent for an invention covered by a patent that was filed at the same time but has a different patent term due to a grant of Patent Term Adjustment (PTA)[1].

Patent Term Adjustment (PTA)

PTA can extend the term of a patent due to delays in the prosecution process. However, terminal disclaimers, often used to overcome ODP rejections, do not extend the patent term past the date of the terminal disclaimer[1].

Inventorship

Proper inventorship is essential for the validity of a patent. Conception, defined as the formation in the mind of the inventor of a definite and permanent idea of the complete and operative invention, is a key factor. Errors in inventorship can be corrected, but deceptive intent can render the patent unenforceable[4].

Role of the Patent Trial and Appeal Board (PTAB)

The PTAB, established by the Leahy-Smith America Invents Act (AIA), plays a crucial role in administrative challenges to patent validity. PTAB reviews patent applications and hears challenges such as Inter Partes Review, ensuring that patents meet the requirements of novelty, nonobviousness, and subject matter eligibility[5].

Practical Implications and Strategies

Crafting Effective Arguments

When facing section 101 rejections, it is important to focus on Prong Two of the subject matter eligibility analysis, highlighting specific technological advancements or solutions to technical problems. This approach can be more persuasive and efficient than lengthy arguments under Prong One[2].

Advanced Patent Searching

Comprehensive patent searches are essential for understanding the scope and coverage of related patents within a family. This involves leveraging tools and strategies to navigate complexities such as multi-jurisdiction filing, indexing inconsistencies, and claims variations[3].

Key Takeaways

  • Subject Matter Eligibility: Ensure claims are directed to specific technological advancements or solutions to technical problems.
  • Obviousness and Double Patenting: Be aware of ODP and the impact of PTA and terminal disclaimers on patent term.
  • Inventorship: Accurately identify inventors and avoid deceptive intent to maintain patent validity.
  • PTAB: Understand the role of PTAB in administrative challenges and ensure compliance with patentability requirements.
  • Claims Analysis: Monitor claim variations during prosecution and ensure comprehensive searches.

FAQs

Q: What is the significance of Prong Two in the subject matter eligibility analysis? A: Prong Two is crucial as it requires demonstrating that the claims are directed to a specific, concrete technological advancement or solution to a technical problem, which is often more persuasive and efficient than arguments under Prong One[2].

Q: How does Patent Term Adjustment (PTA) affect the term of a patent? A: PTA can extend the term of a patent due to delays in the prosecution process, but it does not extend the term past the date of a terminal disclaimer used to overcome ODP rejections[1].

Q: What are the consequences of incorrect inventorship in a patent application? A: Errors in inventorship can be corrected, but deceptive intent can render the patent unenforceable. Correct inventorship is essential for maintaining patent validity[4].

Q: What role does the PTAB play in patent law? A: The PTAB reviews patent applications and hears administrative challenges such as Inter Partes Review, ensuring that patents meet the requirements of novelty, nonobviousness, and subject matter eligibility[5].

Q: Why are comprehensive patent searches important? A: Comprehensive searches help in understanding the scope and coverage of related patents within a family, enabling informed decisions about licensing, challenging validity, and allocating resources to R&D initiatives[3].

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit[1]
  2. The Importance of Prong Two of Step 2A for AI Inventions - Baker Botts[2]
  3. Advanced Patent Searching Techniques - CAS.org[3]
  4. Determining Inventorship for US Patent Applications - Oregon State University[4]
  5. The Patent Trial and Appeal Board and Inter Partes Review - Congressional Research Service[5]

More… ↓

⤷  Try for Free

Details for Patent 10,072,065

ApplicantTradenameBiologic IngredientDosage FormBLAApproval DatePatent No.Expiredate
Eli Lilly And Company ERBITUX cetuximab Injection 125084 February 12, 2004 ⤷  Try for Free 2035-08-24
Eli Lilly And Company ERBITUX cetuximab Injection 125084 March 28, 2007 ⤷  Try for Free 2035-08-24
Genentech, Inc. AVASTIN bevacizumab Injection 125085 February 26, 2004 ⤷  Try for Free 2035-08-24
>Applicant>Tradename>Biologic Ingredient>Dosage Form>BLA>Approval Date>Patent No.>Expiredate
Showing 1 to 3 of 3 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.